Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
Researchers Return to Alzheimer's Vaccines, Buoyed by Recent Drug Success By Julie Steenhuysen CHICAGO (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain ...
Citation: New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions' (2023, November 20) retrieved 5 December 2023 from https://medicalxpress.com ...
Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.
ABOUT A STUDY INVOLVING AN FDA APPROVED DRUG FOR ALZHEIMER’S. THE STUDY IS CALLED AHEAD AND BOTH DUKE AND WAKE FOREST UNIVERSITIES ARE CONDUCTING CLINICAL TRIALS THAT YOU MAY BE ABLE TO JOIN.
The Alzheimer’s epidemic continues to cast a shadow over the lives of millions of people. But researchers believe they are closer than ever before to finding effective treatments.
This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. The new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss ...
Nov. 20—(StatePoint) 2023 was a landmark year for Alzheimer's disease research, including advancements in treatment, risk factors and diagnosis. Here are five significant discoveries made this year: ...
CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
